Drug Shortage Report for NEUROLITE

Last updated on 2022-04-23 History
Report ID 155417
Drug Identification Number 02327848
Brand name NEUROLITE
Common or Proper name Kit for the Preparation of Technetium Tc99m Bicisate for Injection
Company Name LANTHEUS MI CANADA INC
Market Status MARKETED
Active Ingredient(s) BICISATE DIHYDROCHLORIDE
Strength(s) 0.9MG
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size Kits of 2 and kits of 5 vials
ATC code V09A
ATC description
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2022-03-14
Actual start date 2022-04-22
Estimated end date 2022-07-15
Actual end date
Shortage status Actual shortage
Updated date 2022-04-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600
MONTREAL, QUEBEC
CANADA H4M 2X6
Company contact information lmicanada@lantheus.com 1-800-811-5500

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-04-23 English Compare
v5 2022-04-20 French Compare
v4 2022-04-20 English Compare
v3 2022-03-15 English Compare
v2 2022-02-22 French Compare
v1 2022-02-22 English Compare

Showing 1 to 6 of 6